[ad_1]
Whitefish, Montana – 
The U.S. cannabis industry is projected to double in size to $41.5 billion by 2025, according to New Frontier Data, driven by strong consumer demand, greater spending per consumer and the legalization of cannabis in new states. While cannabis flower remains popular, concentrates, edibles and other manufactured products have opened the door to a wider consumer base.
Cannabis flower cultivation is fairly straightforward but concentrates, edibles and other products require a significant investment in manufacturing equipment and space. As a result, it’s cost prohibitive for many brands to manufacture their own products and a lot of legacy brands have been unable to get back into the market with next-gen products.
Let’s take a look at how cannabis co-manufacturing is solving these problems and how investors can participate in the space through companies like FinCanna Capital Corp.(CSE: CALI) (OTCQB: FNNZF) that offers exposure to this exciting industry subset.
CFN recently spoke with The Galley CEO and Co-Founder Annie Holman. Click here to listen
What is Cannabis Co-Manufacturing?
Cannabis co-manufacturing facilities are designed to solve many of the challenges for cannabis brands looking to bring new products to market. These companies help multiple brands confidently bring their ideas to life, launch products and scale more efficiently over time.
Co-manufacturing services can include:
● Sourcing
● Formulation
● Packaging
● Graphic design
● Testing
● Manufacturing and Production
● Storage
Surprisingly, even large companies are beginning to co-manufacture products because they aren’t interested in the high capital costs of manufacturing their own products in-house. They can come in with a recipe and well-defined standard operating procedures and then it’s off to the races.
In some cases, co-manufacturing is also an easier way for existing brands to expand into new states. A cannabis brand in Colorado may be able to use a co-manufacturing operation in California to create and launch their successful recipes and products in California. It’s a lot more cost-effective than rebuilding operations in each state that the brand has products.
The Galley: A Best of Breed Co-Manufacturer
The Galley is a California-based co-manufacturer with an 8,300 sq. ft. facility built to FDA and CDPH standards focused on edibles, topicals, tinctures, chocolates, hard candies, gummies, pre-rolls, flower, vapes and beverages—along with anything else that cannabis brands can dream up. The company even provides distribution and fulfillment services across most of California.
The company’s experienced team includes culinary experts, nutritionists, herbal medicine experts and others that have joined together with the unified goal of making it as easy as possible for brands to turn their ideas into highly successful products. They’re a one-stop shop for bringing cannabis products to market in an efficient and cost-effective way.
In addition to helping other brands, The Galley is developing a best-in-class line of products under its Big Fish brands. The company’s initial products include ocean or sea themed products, such as bath salts that are a beach glass color and a round chocolate ball with a fast-acting powder that looks like a pearl—unique and hard to manufacture products.
The Galley’s CEO Annie Holman believes that, when cannabis opens up for interstate commerce or becomes federally legal, it will be similar to the wine industry. California will become a leader in the market because of its optimal climate, brand expertise and positioning, which will ideally position The Galley in the national market for manufactured cannabis products.
How to Invest in The Galley
FinCanna Capital Corp.(CSE: CALI) (OTCQB: FNNZF), a royalty company operating within the U.S. licensed cannabis industry, has a royalty agreement with The Galley whereby it receives 20% of the company’s revenue paid in cash each month. FinCanna also receives an annual supplemental payment that, when coupled with the royalty, ensures that it receives a minimum of 70% of The Galley’s after-tax net income paid in cash each year. If The Galley is sold, FinCanna is entitled to 70% of the sale proceeds.
In addition to The Galley, FinCanna has royalty agreements with Cultivation Technologies Inc., a multi-award-winning extraction and manufacturing enterprise in Palm Desert, California, as well as ezGreen Compliance, a state-of-the-art enterprise compliance and point-of-sale software solution for licensed cannabis dispensaries and cultivators. These additional businesses provide investors with other sources of high-margin royalty income from different parts of the nascent cannabis industry.
Investors looking for exposure to cannabis co-manufacturing, along with diversified exposure to other parts of the cannabis industry, may want to take a closer look at FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) as a unique way to capitalize on it.
For more information and to view the company’s disclaimer regarding forward looking statements, visit the company’s website or download their investor presentation.
Investor Relations:
Kin Communications
1-866-684-6730
CALI@kincommunications.com
About CFN Enterprises Inc.
CFN Enterprises Inc. (OTCQB: CNFN) is a digital media and ecommerce company focused on advancing businesses and brands in highly regulated emerging industries across the globe. CFN connects investors with new market opportunities while helping consumers find innovative products that enhance their lives. Learn more at www.cfnenterprisesinc.com.
CFN Enterprises Inc. Media Contact:
CFN Enterprises Inc.
+001 (833) 420-CNFN
investors@cfnenterprisesinc.com
FORWARD-LOOKING STATEMENT
Use of Forward-looking Statements
This press release may contain forward-looking statements from CFN Enterprises Inc. within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, when CFN Enterprises Inc. describes FinCanna Capital Corp’s business, and uses other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions, CFN Enterprises Inc. is using forward-looking statements. These forward-looking statements are based on the current expectations of the management of CFN Enterprises Inc. only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial markets; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; we may be unable to retain or attract key employees whose knowledge is essential to the development of our products and services; or, loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of CFN Enterprises Inc. to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, CFN Enterprises Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risk and uncertainties affecting CFN Enterprises Inc., reference is made to CFN Enterprises Inc.’s reports filed from time to time with the Securities and Exchange Commission.
[ad_2]